December 22, 2025 01:37 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi slams ‘cut and commission’ TMC in virtual Taherpur address | US launches Operation Hawkeye Strike in Syria targeting ISIS after Americans killed | Horror on tracks: Rajdhani Express ploughs into elephant herd, eight killed in Assam | Horror in Bangladesh: Hindu man lynched and set on fire amid violent protests | Bangladesh in flames: Student leader Sharif Osman Hadi's death triggers massive protests, media offices torched | Chaos in Dhaka! Protesters assault New Age Editor, burn down newspaper offices amid deadly unrest | After campus shootings, Trump suspends green card lottery programme | ‘Worst is over,’ says IndiGo CEO after flight chaos; staff told to ignore speculation | Chaos at Hyderabad's Lulu Mall! Nidhhi Agerwal swarmed by fans, police register case | TCS bets big on AI, shares spike as company reveals ambitious plan
COVID19
Pixabay

US centers for disease control backs panel proposal for initial COVID-19 vaccine doses

| @indiablooms | Dec 04, 2020, at 02:59 pm

Washington/Sputnik: The US Centers for Disease Control and Prevention (CDC) adopted recommendations from an advisory panel that the first doses of a coronavirus vaccine be reserved for elderly care residents and health workers, according to a press release.

''[CDC Director Robert] Redfield supports their recommendations and has signed the memo and accepted these interim recommendations,'' the release said on Thursday.

On Tuesday, the CDC’s Advisory Committee on Immunization Practices recommended that initial vaccinations target 3 million residents in elderly care facilities and a portion of the nation’s 21 million healthcare workers.

Health workers such as nurses, whose jobs routinely place them within six feet of other people, would be first to receive the vaccine followed by workers able to follow CDC social distancing guidelines, the Advisory Committee said.

Vaccines made by Pfizer and Moderna have applied for emergency use authorization from the US Food and Drug Administration amid expectations of quick approval with first doses administered later this month. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.